The recently hyped amoeba-flagellate Collodictyon has many secrets to tell about early eukaryotic evolution.
The recently hyped amoeba-flagellate Collodictyon has many secrets to tell about early eukaryotic evolution.
ALS patients take their fate into their own hands, self-administering an unapproved chemical and collating their results online.
Silk impregnated with bleach may provide a new way to fight the formidable spores of the anthrax bacterium.
Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
Wales creates a database of DNA barcodes for all of its native flowering plants, hoping to guide conservation and drug development efforts.
Medical devices coated with selenium nanoparticles reduce the growth of a deadly hospital-borne infection.
Some of the interesting stories researchers were discussing at this year’s American Society of Microbiology meeting in San Francisco.
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
Industry experts discuss the agency’s plans to make the drug approval process more transparent.